Search Results - "Barbarot, S"

Are adolescents with atopic eczema really undertreated in real life? by Barbarot, S.

“…Linked Article: Lundin et al. Br J Dermatol 2018; 179:709–716…”
Get full text

Epidemiology of atopic dermatitis in adults: Results from an international survey by Barbarot, S., Auziere, S., Gadkari, A., Girolomoni, G., Puig, L., Simpson, E. L., Margolis, D. J., Bruin‐Weller, M., Eckert, L.

“…Background There are gaps in our knowledge of the prevalence of adult atopic dermatitis (AD). Objective To estimate the prevalence of AD in adults and by…”
Get full text

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I by Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., Czarnecka‐Operacz, M., Schäfer, T., Schmid‐Grendelmeier, P., Simon, D., Szalai, Z., Szepietowski, J.C., Taïeb, A., Torrelo, A., Werfel, T., Ring, J.

“…This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a…”
Get full text

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II by Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., Czarnecka‐Operacz, M., Schäfer, T., Schmid‐Grendelmeier, P., Simon, D., Szalai, Z., Szepietowski, J.C., Taïeb, A., Torrelo, A., Werfel, T., Ring, J.

“…This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a…”
Get full text

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children by Wollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J.P., Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M.J., Kunz, B., Fölster‐Holst, R., Trzeciak, M., Darsow, U., Szalai, Z., Deleuran, M., Kobyletzki, L., Barbarot, S., Heratizadeh, A., Gieler, U., Hijnen, D.J., Weidinger, S., De Raeve, L., Svensson, Å., Simon, D., Stalder, J.F., Ring, J.

“…Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

Revisiting neurocutaneous melanosis spectrum: do we have to undertake systematic magnetic resonance imaging in children with congenital melanocytic naevi? by Barbarot, S.

Get full text

Atopic dermatitis and type-1 diabetes mellitus: a true positive association? by Ezzedine, K., Barbarot, S.

“…Linked Article: Lin, et al. Br J Dermatol 2016; 174: 88–94…”
Get full text

Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials by Barbarot, S., Wollenberg, A., Silverberg, J. I., Deleuran, M., Pellacani, G., Armario-Hita, J. C., Chen, Z., Shumel, B., Eckert, L., Gadkari, A., Lu, Y., Rossi, A. B.

“…Dupilumab, a first-in-class therapy targeting the two key cytokines involved in the persistent underlying inflammatory pathway in atopic dermatitis (AD), is…”
Get full text

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients by Wollenberg, A., Oranje, A., Deleuran, M., Simon, D., Szalai, Z., Kunz, B., Svensson, A., Barbarot, S., von Kobyletzki, L., Taieb, A., de Bruin-Weller, M., Werfel, T., Trzeciak, M., Vestergard, C., Ring, J., Darsow, U.

“…Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using…”
Get full text

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period by Vestergaard, C., Wollenberg, A., Barbarot, S., Christen‐Zaech, S., Deleuran, M., Spuls, P., Flohr, C., Trzeciak, M., von Kobyletzki, L., Seneschal, J., Paul, C., Bieber, T., Werfel, T., Fölster‐Holst, R., Darsow, U., Gieler, U., Svensson, Å., Cork, M., Stalder, J.‐F., De Raeve, L., Kunz, B., Simon, D., Chernyshov, P., Hijnen, D., Gelmetti, C., Ring, J., Taieb, A., de Bruin‐Weller, M., Thyssen, J.P.

“…Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age…”
Get full text

COVID‐19 lockdown induced acral dermatosis in children by Bodak, N., Chiaverini, C., Barbarot, S.

Get full text

Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency by Aubert-Wastiaux, H., Moret, L., Le Rhun, A., Fontenoy, A.M., Nguyen, J.M., Leux, C., Misery, L., Young, P., Chastaing, M., Danou, N., Lombrail, P., Boralevi, F., Lacour, J.P., Mazereeuw-Hautier, J., Stalder, J.-F., Barbarot, S.

“…Summary Background  Topical corticosteroids remain the mainstay of atopic dermatitis therapy. Many atopic dermatitis therapeutic failures appear to be…”
Get full text

Therapeutic patient education in atopic eczema by Barbarot, S., Stalder, J.F.

“…Summary Therapeutic patient education (TPE) is a patient‐centred process that entails the transfer of skills (e.g. self‐management, treatment adaptation) from…”
Get full text

The Patient‐Oriented Scoring of Atopic Dermatitis and SCORAD in young children: New data on interpretability and clinical usefulness by Barbarot, S., Aubert, H., Stalder, J.‐F., Roye, S., Delarue, A.

“…Background There is limited data about the clinical meaningfulness of the Scoring of Atopic Dermatitis (SCORAD) and Patient‐Oriented SCORAD (PO‐SCORAD),…”
Get full text

Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score by Stalder, J.‐F., Aubert, H., Anthoine, E., Futamura, M., Marcoux, D., Morren, M.‐A., Trzeciak, M., Szalai, Z., Veres, K., Deleuran, M., Vestergaard, C., Boralevi, F., Chu, C.‐Y., De Raeve, L., Svensson, Å., Fölster‐Holst, R., Buchner, M., Takaoka, R., Aoki, V., Chernyshov, P., Chernyshova, L., Murrell, D. F., Zhao, C., Mckinster, C. D., Von Kobyletzky, L., Eichenfield, L., Totri, C., Lio, P., Seneschal, J., Moret, L., Barbarot, S.

“…Background Adherence to topical corticosteroids (TCS) is essential for the effective treatment of atopic dermatitis but can be limited by concerns about their…”
Get full text

What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials by Nankervis, H., Thomas, K.S., Delamere, F.M., Barbarot, S., Smith, S., Rogers, N.K., Williams, H.C.

“…Summary Atopic eczema (AE) is a common chronic inflammatory skin condition. While many AE treatment options are available, the evidence to support their…”
Get full text

Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing by Le Cleach, L., Dousset, L., Assier, H., Fourati, S., Barbarot, S., Boulard, C., Bourseau Quetier, C., Cambon, L., Cazanave, C, Colin, A., Kostrzewa, E., Lesort, C., Levy Roy, A., Lombart, F., Marco‐Bonnet, J., Monfort, J.‐B., Samimi, M., Tardieu, M., Wolkenstein, P., Sbidian, E., Beylot‐Barry, M.

“…Summary Background Acral lesions, mainly chilblains, are the most frequently reported cutaneous lesions associated with COVID‐19. In more than 80% of patients…”
Get full text

The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada by de Bruin‐Weller, M., Gadkari, A., Auziere, S., Simpson, E.L., Puig, L., Barbarot, S., Girolomoni, G., Papp, K., Pink, A.E., Saba, G., Werfel, T., Eckert, L.

“…Background Cross‐sectional data on patient burden in adults with atopic dermatitis (AD) from real‐world clinical practice are limited. Objective This study…”
Get full text